HR10212Referred to Committee

To direct the Secretary of Veterans Affairs to study the potential benefits of peptide-based therapies for veterans receiving care through the Department of Veterans Affairs, and for other purposes.

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2026-09-01
Introduced
0
Cosponsors
HR
ⓘ
Type

Sponsor

Nancy Mace
Nancy Mace
Republican · SC · Representative
Votes with party: 93.4% (529 recorded votes)

Full profile: /officials/M000194

Source: Congress.gov · FEC

Cosponsors (0)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

No cosponsors on record. Bills can pass without cosponsors — this often means the sponsor introduced the bill alone, either because it's a messaging bill, a chairman's mark, or simply early in the legislative cycle.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Veterans' Affairs.

2026-09-01

Source: Congress.gov

Committee Activity

Currently in

Plain-English Summary

Plain-English summary pending. Introduced on 2026-09-01. Check back soon — summaries are generated as bills progress through Congress.

Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.